LEESBURG, VA … September 15, 2009 – K2M, Inc., the spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced the launch of the NATURAL BRIDGE® Low Profile (LP) Transverse Connectors to provide optimal torsional stabilization in the thoracolumbar spine. The uniquely designed low volume polyaxial heads snap onto the rod, allowing for ease of introduction while offering the surgeon tactile feedback when implanting.
More »
PLAINSBORO, N.J., Sep 14, 2009 (GlobeNewswire via COMTEX News Network) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Integra Spine has acquired substantially all of the assets of Innovative Spinal Technologies, Inc. (IST) for $9.25 million in cash.
IST designed, developed, manufactured, and sold spinal implant products focused on minimally invasive surgery (MIS) and motion preservation techniques. The product lines acquired in the transaction include the Paramount(R) MIS / Open system for percutaneous lumbar fusion procedures, the Paramount(R) interbody fusion system, and the Cordant(TM) anterior cervical plating system, as well as the product development assets related to IST’s Axient(TM) product line for posterior dynamic stabilization. Integra Spine acquired IST’s portfolio of over 100 U.S. and foreign patents and patent applications, its trademarks, and its product inventory, and assumed certain of its patent license agreements.
More »
Όπως είχε εξαγγείλει ο Πανελλήνιος Σύλλογος Προμηθευτών Εμφυτεύσιμου Ορθοπαιδικού Υλικού (ΠΑΣΥΠΟΥ), παύει από τις 10 Σεπτεμβρίου να προμηθεύει τα νοσοκομεία της χώρας τα οποία έχουν ανεξόφλητα χρέη προς τα μέλη του που ξεπερνούν τους 6 μήνες εξελικτικά. Ο Σύλλογος που σε προηγούμενη ανακοίνωσή του είχε κάνει λόγο για εμπαιγμό αποφάσισε να μην δεχτεί την πρόταση του Ταχυδρομικού Ταμιευτηρίου για την εξόφληση των χρεών μέσω της τράπεζας και να προχωρήσει στο «πάγωμα» των προμηθειών προς τα νοσοκομεία. Την απόφασή του ανακοίνωσε με επιστολή του προς τον Υπουργό Υγείας και Κοινωνικής Αλληλεγγύης, κ. Δημήτρη Αβραμόπουλο και τους διοικητές των νοσοκομείων και των ΥΠΕ. More »
WALTHAM, Mass.–(BUSINESS WIRE)–Sep. 8, 2009– Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has approved DuraSeal™ spine sealant for use in the United States. This is the first product that has been approved specifically as an adjunct to suturing for intra-operative dural sealing in spine procedures. More »
| Nuvasive, Inc. | 32.77 | ||
| Zimmer Holdings, | 52.99 | ||
| Alphatec Holdings | 4.23 | ||
| Smith & Nephew Sn | 43.62 | ||
| Trans1 Inc. | 2.49 | ||
| Medtronic Inc. Co | 36.97 | ||
| Synthes | 119.80 | ||
| Rti Biologics, In | 2.89 | ||
| Johnson & Johnson | 58.09 | ||
| Orthofix Internat | 30.28 | ||
| Covidien Plc. Ord | 37.32 | ||
| Orthovita, Inc. | 1.85 |
Archive for Publications »
